Tensor Surgical

Executive Summary

Tensor Surgical is a US-based medical device company developing anchorless arthroscopic transosseous repair systems for soft tissue orthopedic procedures, primarily rotator cuff repair and biceps tenodesis. Founded in 2017 and headquartered in Nashville, Tennessee, the company's flagship technology eliminates the need for suture anchors, aiming to improve biological healing by preserving native bone-tendon interface and reduce overall procedural costs. Tensor Surgical positions itself as the 'Gold Standard repair' aligned with value-based care principles, offering a solution that could disrupt the current anchor-based paradigm in arthroscopic surgery. The company's transosseous approach may also mitigate complications associated with anchors, such as anchor loosening or osteolysis, while potentially accelerating patient recovery and return to function. As a private entity with no disclosed funding rounds or valuation, Tensor Surgical operates in the competitive orthopedic device market, targeting the large and growing rotator cuff repair segment. Its value proposition centers on improved clinical outcomes and cost savings for healthcare systems, which is increasingly relevant as payers shift toward bundled payments and quality metrics. While the company has not publicly announced commercial milestones, its technology appears poised to capture interest from surgeons seeking alternatives to traditional suture anchors. Key challenges include proving clinical superiority in head-to-head trials, navigating FDA regulatory pathways, and building a sales force to compete with established players like Arthrex and Smith+Nephew.

Upcoming Catalysts (preview)

• Q2 2026FDA 510(k) Clearance for Transosseous Repair System75% success
• Q4 2026First-in-Human Clinical Study Results60% success
• H1 2027Strategic Partnership or Distribution Agreement50% success